6 drug(s) with this reaction
2,959 total reports
Diabetes Mellitus has been reported as an adverse reaction across 6 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 2,959 adverse event reports mention diabetes mellitus in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with diabetes mellitus, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have diabetes mellitus listed in their FDA adverse event reports, sorted by report count:
In addition to diabetes mellitus, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
6 drug(s) manufactured by Abbvie Inc have diabetes mellitus listed in their FDA adverse event reports: DIVALPROEX SODIUM, FENOFIBRATE, RISANKIZUMAB-RZAA, PANCRELIPASE, RITONAVIR, and others.
There are a combined 2,959 reports of diabetes mellitus across 6 Abbvie Inc drug(s) in the FDA adverse event database.